THE INVOLVEMENT OF SMALL VESSELS IN BUERGER'S DISEASE IN THEIR CLINICOPATHOLOGICAL CORRELATION
- Letter to the Editor. Kolbakir, Fersat; Erk, M. Kamuran // Vascular Surgery;Jul/Aug1993, Vol. 27 Issue 6, p479
Presents a letter to the editor in response to the article "Thromboangiitis Obliterans (Buerger's disease) in a Cigarette Factory Worker," by YÃ¶ruko&gcaron;lu et al in a 1992 issue of "Vascular Surgery."
- Letter to the Editor. Yörukoglu // Vascular Surgery;Jul/Aug1993, Vol. 27 Issue 6, p479
Presents a response by YÃ¶ruko&gcaron;lu et al to a letter to the editor about their article "Thromboangiitis Obliterans (Buerger's disease) in a Cigarette Factory Worker," in a 1992 issue of "Vascular Surgery."
- Treatment-of-choice for Buerger’s disease (thromboangiitis obliterans): still an unresolved issue. Paraskevas, Kosmas I. // Clinical Rheumatology;Apr2008, Vol. 27 Issue 4, p547
A letter to the editor is presented in response to an article related to Buerger's disease.
- Reply: â€œTreatment-of-choice for Buergerâ€™s disease (thromboangiitis obliterans): still an unresolved issueâ€. Tavakoli, Hassan; Salimi, Javad; Rashidi, Armin // Clinical Rheumatology;Jun2008, Vol. 27 Issue 6, p813
A response by Hassan Tavakoli and colleagues to a letter to the editor about their article "Treatment-of-Choice for Buerger's Disease (Thromboangiitis Obliterans): Still an Unresolved Issue" published in a previous issue of the journal is presented.
- A challenging case of thromboangiitis obliterans. Abdullah, Ahmad; Hayden, Anna; Gabana, Cori Ann; Appleton, Brent Evan // British Columbia Medical Journal;Apr2016, Vol. 58 Issue 3, p126
Thromboangiitis obliterans, or Buerger disease, is a rare, idiopathic, occlusive vascular disease that is strongly associated with smoking and tobacco use. Among patients with peripheral vascular disease, reported prevalence ranges from 45% to 63% in India and 16% to 66% in Korea and Japan, to...
- Antiphospholipid antibodies in thromboangiitis obliterans. Maslowski, Leszek; McBane, Robert; Alexewicz, Pawel; Wysokinski, Waldemar E // Vascular Medicine;2002, Vol. 7 Issue 4, p259
Thromboangiitis obliterans (TAO) and antiphospholipid syndrome (APS) share the clinical characteristics of arterial thrombosis and recurrent thrombophlebitis. Although the association of anticardiolipin antibodies (aCLa) and TAO has been previously recognized, the prevalence and the clinical...
- Are anticardiolipin antibodies really important in thromboangiitis obliterans (Buerger's disease)? Olin, Jeffrey W // Vascular Medicine;2002, Vol. 7 Issue 4, p257
Studies the effect of anticardiolipin antibodies (aCLa) on patients with thromboangiitis obliterans. Role of immunological mechanism in vascular inflammation; Use of double antibody sandwich enzyme-linked immunosorbent assay aCLa.
- Enhanced Platelet Force Development Despite Drug-Induced Inhibition of Platelet Aggregation in Patients with Thromboangiitis Obliterans. Carr, Marcus E.; Hackney, Mary H. // Vascular & Endovascular Surgery;Nov/Dec2002, Vol. 36 Issue 6, p473
Thromboangiitis obliterans (TAO) is a nonatherosclerotic, nonnecrotizing, nonspecific, segmental inflammatory obliterative vasculitis, characterized by decreased flow to the distal extremities and increased risk of amputation. While smoking cessation is viewed as critical to successful...
- Buerger's Disease Retrieved . // Annals of Internal Medicine;Aug61, Vol. 55 Issue 2, p339
Editorial. Discusses various aspects of argument on Buerger's disease. Patient characteristics; Distinctions between Buerger's disease and arteriosclerosis.